FR
FR EN
news-homepage-EN, news-pressroom-EN avril 23, 2026 vantagebiotrials Comments: 0

Vantage BioTrials Joins AI Collaboration to Advance Clinical Trial Intelligence and Improve Trial Execution with TrialsBank™

  April 20, 2026, Montréal, Canada – Vantage BioTrials, a leading Canadian Contract Research Organization (CRO) specializing in clinical trial management services, is proud to announce its participation in a strategic scientific collaboration with Sorintellis, Université de Montréal, Université Laval and IVADO. The collaboration aims to advance a next-generation AI-powered clinical trial intelligence platform, TrialsBank™, designed to improve clinical trial execution, patient outcom...
Read More
news-homepage-EN, news-pressroom-EN avril 20, 2026 vantagebiotrials Comments: 0

Vantage BioTrials Joins CanReview Partner Network to Support Faster Clinical Trial Start-Up in Canada

  April 20, 2026, Montréal, Canada – Vantage BioTrials, a leading Canadian Contract Research Organization (CRO) specializing in clinical trial management services, is proud to support CanReview, a pan-Canadian collaboration supported by the Accelerating Clinical Trials (ACT) Consortium to build a broadly accessible, Canada-wide single research ethics review system that will enable all research sites participating in a multi-site clinical trial to undergo one ethics review, while ensuring...
Read More
news-homepage-EN, news-pressroom-EN octobre 1, 2025 vantagebiotrials Comments: 0

Vantage BioTrials Awarded Phase 3 Clinical Trial in Substance Use Disorder

October 1, 2025, Montréal, Canada – Vantage BioTrials, a leading Canadian Contract Research Organization (CRO) specializing in clinical trial management services, is proud to announce its award and upcoming role in managing a pivotal Phase III randomized, double-blind, placebo-controlled clinical trial in the field of Substance Use Disorder. The study, sponsored by a biopharmaceutical company, aims to evaluate the safety and efficacy of an investigational approach for improving clinical relia...
Read More
news-homepage-EN, news-pressroom-EN juin 13, 2025 vantagebiotrials Comments: 0

Vantage BioTrials Recognized as Finalist for the 2025 Partnership Award

June 11, 2025, Montréal, Canada – Vantage BioTrials is proud to announce that it has been named a finalist for the esteemed 2025 Partnership Award, a prestigious award recognizing outstanding collaborative projects within Quebec’s innovation ecosystem. This accolade celebrates the successful partnership between Vantage BioTrials, Groupe Sorintellis, and the Centre de Recherche Informatique de Montréal (CRIM), underscoring a shared commitment to advancing clinical research through innovatio...
Read More
White Papers-FR mars 23, 2024 vantagebiotrials Comments: 0

Prioritizing Agility When Choosing a Contract Research Organization

Prioritizing Agility When Choosing a Contract Research Organization Publication date: September 2023 / Download PDFAuthor: Josée Comeau Introduction Throughout the years, the field of clinical research has continued to grow in complexity and has encountered numerous challenges, and although processes have been well established, many of us have settled into a daily routine that maintains the status quo. It’s time for us to move away from traditional practices and introduce a concept that some...
Read More
White Papers-FR février 1, 2024 vantagebiotrials Comments: 0

Criteria for Choosing a Great Contract Research Organization (CRO)

Criteria for Choosing a Great Contract Research Organization (CRO) Publication date: February 2024 / Download PDF Author: Viken Bartekian Introduction Outsourcing is often a necessity within the health care industry. Many pharmaceutical, biotechnology and medical device companies rely on outsourcing to Contract Research Organizations (CROs) as part of their strategy to advance to the next stage of clinical trials. As a matter of perspective, the CRO market size is expected to grow by USD 63.35 b...
Read More
news-pressroom-EN novembre 22, 2023 vantagebiotrials Comments: 0

Vantage BioTrials Awarded Phase 1b ARDS Trial

November 1, 2023, Montréal, Canada – Vantage BioTrials, a full-service Contract Research Organization (CRO), has partnered with a US-based biotech to lead all clinical trial management activities of their Phase Ib Dose Escalation followed by Phase II randomized, placebo controlled, blinded end-point trial in patients with Acute Respiratory Distress Syndrome (ARDS), including COVID-19 patients. The dose escalation phase of the study will inform the safety profile of the Sponsor’s Investigat...
Read More
White Papers-FR septembre 1, 2023 vantagebiotrials Comments: 0

Prioritizing Agility When Choosing a Contract Research Organization

Prioritizing Agility When Choosing a Contract Research Organization Publication date: September 2023 / Download PDF Author: Josée Comeau Introduction Throughout the years, the field of clinical research has continued to grow in complexity and has encountered numerous challenges, and although processes have been well established, many of us have settled into a daily routine that maintains the status quo. It’s time for us to move away from traditional practices and introduce a concept that some...
Read More
news-pressroom-EN août 26, 2023 vantagebiotrials Comments: 0

President of Vantage BioTrials Interviewed by Pharmaboardroom on the State of Clinical Trials in Canada

Vantage BioTrials’ President, Vatche Bartekian, was recently interviewed by Pharmaboardroom on ways that the company focuses on operational excellence with a lean and holistic approach to each project and how they continually advocate for greater visibility for Canada on the international stage and an increase in collaboration within the pharmaceutical industry and regulatory bodies. “What we can observe in Canada is a very diverse CRO landscape, in which each player has found its ow...
Read More
news-pressroom-EN août 26, 2023 vantagebiotrials Comments: 0

President of Vantage BioTrials Interviewed by CATALIS on the State of Clinical Trials Industry in Quebec During the COVID-19 Crisis

The future of clinical research after COVID-19 How will this crisis affect the clinical trial industry in Quebec? Just like in other industries, this pandemic, unfortunately, had an immediate impact on the pharmaceutical industry and notably clinical trials. The multiple restrictions limiting physical interactions between people entails many challenges and a multitude of projects that have been curtailed, postponed or even canceled. In the past weeks, we have observed four major problems linked...
Read More
FR
FR EN